Cargando…

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. The serum level of soluble CD163 (sCD163), a macrophage activation marker, is associated with liver tissue changes; however, its prognostic value is unknown. Here, we determined the utility of sCD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawanaka, Miwa, Nishino, Ken, Kawada, Mayuko, Ishii, Katsunori, Tanikawa, Tomohiro, Katsumata, Ryo, Urata, Noriyo, Nakamura, Jun, Suehiro, Mitsuhiko, Haruma, Ken, Kawamoto, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173513/ https://www.ncbi.nlm.nih.gov/pubmed/37165352 http://dx.doi.org/10.1186/s12876-023-02786-4

Ejemplares similares

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Efficacy of endoscopic ultrasound‐guided abscess drainage for non‐pancreatic abscesses: A retrospective study
por: Tanikawa, Tomohiro, et al.
Publicado: (2023)

High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2019)

Afferent-Loop Syndrome Treated with Endoscopic Ultrasound-Guided Drainage of the Afferent Loop with a Plastic Stent
por: Tanikawa, Tomohiro, et al.
Publicado: (2022)

Efficacy of primary drainage by endoscopic ultrasound‐guided biliary drainage for unresectable pancreatic adenocarcinoma
por: Tanikawa, Tomohiro, et al.
Publicado: (2022)

Treatment of ectopic variceal bleeding at choledochojejunostomy by endoscopic glue injection therapy with cyanoacrylate: Report of three cases including long‐term outcomes
por: Tanikawa, Tomohiro, et al.
Publicado: (2022)

Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
por: Urata, Noriyo, et al.
Publicado: (2020)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
por: Kawanaka, Miwa, et al.
Publicado: (2013)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2015)

Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia
por: Katsumata, Ryo, et al.
Publicado: (2023)

Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
por: Yasugi, Kengo, et al.
Publicado: (2021)

Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors
por: Nishino, Ken, et al.
Publicado: (2022)

Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis: A Case Suggesting the “Gastrin Link Theory”
por: Nishino, Ken, et al.
Publicado: (2020)

Two Cases of Acute Gastric Mucosal Lesions Due to Helicobacter pylori Infection Confirmed to be Transient Infection
por: Suehiro, Mitsuhiko, et al.
Publicado: (2022)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma
por: Katsumata, Ryo, et al.
Publicado: (2022)

Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer()
por: Katsumata, Ryo, et al.
Publicado: (2022)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
por: Mueller, Jessica L, et al.
Publicado: (2015)

A Case of Autoimmune Gastritis and Hepatitis with Enlarging Gastric Polyps after Reducing the Dose of Prednisolone
por: Katsumata, Ryo, et al.
Publicado: (2023)

Helicobacter pylori-Negative Advanced Gastric Cancer Arising from the Gastric Mucosa without Inflammation, Atrophy, or Intestinal Metaplasia
por: Hayashi, Jiro, et al.
Publicado: (2022)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

A case of idiopathic gastric intramural hematoma diagnosed using contrast-enhanced ultrasonography and followed up with conservative treatment
por: Nakamura, Jun, et al.
Publicado: (2022)

Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis
por: Suwa, Kanehiko, et al.
Publicado: (2020)

Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis
por: Yamaguchi, Takashi, et al.
Publicado: (2022)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
por: Kita, Yuki, et al.
Publicado: (2012)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
por: Miyagawa, Sawa, et al.
Publicado: (2023)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_70d6aovqd6k051jnvhsa0eri51